Universal Cancer Vaccine Being Tested
A vaccine that targets a molecule in 90% of all cancers is now being tested on humans.
Results from the safety trial – on patients with blood cancer – found all had greater immunity to the disease after receiving the vaccine. Three of the seven patients who have completed the treatment are now free of the condition.
As a therapeutic vaccine it is designed to be given to patients to help their bodies fight cancer rather than the majority – known as prophylactic vaccines – that aim to prevent disease in the first place.
Researchers believe the jab could also tackle breast, prostate, pancreatic, bowel and ovarian cancers.